Page 39 - Markets

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Motilal Oswal retains 'Buy' on JSW Infra as FY30 growth roadmap strengthens

With a balanced east-west coast presence and expanding inland logistics capabilities, JSWINFRA, analysts believe, is well-placed to benefit from India's push for multimodal integration

Hero MotoCorp accelerates on EV surge, rural push, says Nirmal Bang; 'Buy'

The brokerage turn incrementally constructive on Hero given improving domestic share trends, rural demand tailwinds, strengthening EV ramp-up, and strong export momentum

Stocks to Watch today, Dec 5: IndiGo, banks, auto, ITC Hotels, Adani Ent

Stocks to Watch, Friday, Dec 5: Rate sensitive stocks, RailTel, Samvardhana Motherson, IndusInd Bank, Deepak Nitrite, and Tata Power are some other stocks to watch today

Avoid exiting Balanced Advantage Funds based on short-term underperformance

Balanced Advantage Funds have had a weak year, but advisors warn against knee-jerk exits, saying investors should stay invested unless a fund persistently lags peers and benchmarks

JM Financial starts coverage on KPR Mill with 'Buy'; check target price

JM Financial has set a target price of ₹1,215 per share, implying an upside potential of 21 per cent

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Mphasis up 2% on innovation program update; PL Capital upgrades to 'Buy'

Domestic brokerage PL Capital has upgraded its rating on Mphasis shares to 'Buy' from 'Accumulate', with a revised target price of ₹3,310 per share

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Here's why Adani Enterprises share price rose 2% in trade on December 4

Adani Enterprises informed the exchanges that AdaniConneX Private Limited, a joint venture of the company, has incorporated a wholly owned subsidiary (WOS) namely 'AdaniConneX Hyderabad Three Limited'

DIC India shares gain 5% after Karnataka GST authorities slash penalty

The upward movement in DIC India's share price came after the Karnataka GST department revised the total GST demand against the company to ₹3.81 lakh from ₹6.71 crore

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Motilal Oswal retains 'Buy' on Aurobindo Pharma as FY26-28 prospects shine

Tushar Manudhane, Vipul Mehta, and Eshita Jain, research analysts at MOFSL, value Aurobindo Pharma at 16 times 12-month forward earnings, assigning a target price of ₹1,430

Nuvama reiterates 'Buy' on Embassy REIT; here's why growth looks strong

Parvez Qazi and Vasudev Ganatra, research analysts at Nuvama, expect Embassy REIT to clock a DPU compound annual growth rate (CAGR) of 13 per cent over FY25-28E on the back of strong office demand

Stocks to Watch today: RIL, IEX, Cipla, JSW Steel, IndiGo, RailTel Corp

Stocks to Watch Today, December 4, 2025: Infosys, Pine Labs, ONGC, Bank of Maharashtra, Tata Capital, Lemon Tree Hotels, Vintage Coffee are among the top stocks to watch today

Emmvee Photovoltaic gains 4%, hits all-time high on strong Q2 performance

Emmvee Photovoltaic stock was trading at ₹243.5, up 1.85 per cent compared to the previous session's close of ₹239.35 on the NSE

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Is Bank of Maharashtra a good PSU bank stock to buy? YES Securities answers

YES Securities said that a detailed analysis of top eight public sector banks (PSBs) reveal that Bank of Maharashtra has the "healthiest" financial metrics.

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times